287 related articles for article (PubMed ID: 25169217)
1. The serum tryptase test: an emerging robust biomarker in clinical hematology.
Valent P; Sperr WR; Sotlar K; Reiter A; Akin C; Gotlib J; Horny HP; Arock M
Expert Rev Hematol; 2014 Oct; 7(5):683-90. PubMed ID: 25169217
[TBL] [Abstract][Full Text] [Related]
2. Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.
Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C
Int Arch Allergy Immunol; 2019; 180(1):44-51. PubMed ID: 31256161
[TBL] [Abstract][Full Text] [Related]
3. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
4. Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology.
Sperr WR; El-Samahi A; Kundi M; Girschikofsky M; Winkler S; Lutz D; Endler G; Rumpold H; Agis H; Sillaber C; Jäger U; Valent P
Eur J Clin Invest; 2009 Oct; 39(10):914-23. PubMed ID: 19522836
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
6. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.
Waters AM; Park HJ; Weskamp AL; Mateja A; Kachur ME; Lyons JJ; Rosen BJ; Boggs NA
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2424-2435.e5. PubMed ID: 35032694
[TBL] [Abstract][Full Text] [Related]
7. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
Sperr WR; Horny HP; Lechner K; Valent P
Leuk Lymphoma; 2000 May; 37(5-6):473-86. PubMed ID: 11042508
[TBL] [Abstract][Full Text] [Related]
9. [Mastocytosis and eosinophilic leukemia: diagnostics and classification].
Sotlar K; Valent P; Horny HP
Pathologe; 2012 Nov; 33(6):539-52. PubMed ID: 23085697
[TBL] [Abstract][Full Text] [Related]
10. Disease spectrum in patients with elevated serum tryptase levels.
Aberer E; Savic S; Bretterklieber A; Reiter H; Berghold A; Aberer W
Australas J Dermatol; 2015 Feb; 56(1):7-13. PubMed ID: 24575854
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.
Klion AD; Noel P; Akin C; Law MA; Gilliland DG; Cools J; Metcalfe DD; Nutman TB
Blood; 2003 Jun; 101(12):4660-6. PubMed ID: 12676775
[TBL] [Abstract][Full Text] [Related]
12. Inherited and acquired determinants of serum tryptase levels in humans.
Lyons JJ
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):420-426. PubMed ID: 34175497
[TBL] [Abstract][Full Text] [Related]
13. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
14. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
15. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.
Sperr WR; Jordan JH; Baghestanian M; Kiener HP; Samorapoompichit P; Semper H; Hauswirth A; Schernthaner GH; Chott A; Natter S; Kraft D; Valenta R; Schwartz LB; Geissler K; Lechner K; Valent P
Blood; 2001 Oct; 98(7):2200-9. PubMed ID: 11568008
[TBL] [Abstract][Full Text] [Related]
16. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.
Bibi S; Arslanhan MD; Langenfeld F; Jeanningros S; Cerny-Reiterer S; Hadzijusufovic E; Tchertanov L; Moriggl R; Valent P; Arock M
Haematologica; 2014 Mar; 99(3):417-29. PubMed ID: 24598853
[TBL] [Abstract][Full Text] [Related]
17. [Tryptase: A practical guide for the physician].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042
[TBL] [Abstract][Full Text] [Related]
18. Mast cell tryptase in sera of patients with Crohn's disease and mastocytosis.
de Rossi TM; Krauss N; Wilken V; Giera B; Konturek PC; Kressel J; Hahn EG; Raithel M
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):273-7. PubMed ID: 19279472
[TBL] [Abstract][Full Text] [Related]
19. Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.
Akin C; Soto D; Brittain E; Chhabra A; Schwartz LB; Caughey GH; Metcalfe DD
Clin Immunol; 2007 Jun; 123(3):268-71. PubMed ID: 17449330
[TBL] [Abstract][Full Text] [Related]
20. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN; Natkunam Y
J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
